Lists
Simple alphabetical listing of much of the website content by location within the website.
- Alternative (Survey Choice)
- Across-the-Board Cost Cutting
- Alliances, Acquisitions and Open Source Research
- Commercialization
- Evidence Gathering
- Governance
- Leadership
- Major Product Liability Case
- Management of Risk & Uncertainty
- Merger and Acquisition Activity
- Old School R&D Leadership
- Organizational Behaviors
- Outsourcing
- Rushed Commercialization
- Staff Development
- Technology or Science Breakthroughs
- Editors’ Pick
- A Disturbing Thought
- Across-the-Board Cost Cuts
- Advantages of In-Sourcing
- All Your Eggs in One Basket
- Analogous Thinking
- Artificial Deadlines or Deadline Bias
- Assuaging Investor Anxieties
- Behaviors are ugly
- Behaviors Couldn't Get Any Worse
- Black Swan
- Bodies of Evidence
- Buddy N.
- Build It and They'll Come
- Building Blocks of Eventual Success
- Case Study – #005 Colleagues at Each Other’s Throats
- Chance, Nécessité, et Naïveté
- Checklists, Cheap Heuristics
- Decline of the Pharmaceutical Industry
- Disconfirming Evidence and Blockbuster Drugs
- Disconfirming Evidence, The Process
- Discontinuous Discovery
- Domino Causality
- DRGs and Process Optimization aka Sigma
- Drug Safety and Grandma
- Efficiency vs. Effectiveness
- Elimination of Investigator Bias
- Execution is the Key to Success
- Fab Five
- Flexibility of Pursuit in R&D
- Franchise Benefits
- Franchise Fees & The Tyrant
- Franchisee-In-Charge
- Free Market R&D
- Free-Format Proposal
- Freedom and Dissention
- From Factory R&D to Entrepreneurial R&D
- Generalization
- Genesis of World Class R&D
- Gestalt
- Government Response to Pharma in Decline - Editorial
- Heterogeneity of the Placebo Effect
- How much does it cost for that train to move a ton of freight?
- How Science Progresses
- Human Condition
- Humor Submission
- Illogical R&D
- Independent Evaluation Defined
- Inference then Observation
- Insurance
- Intellectual Capital
- Intellectual Capital Valuation LLC
- Intellectual Property Repository
- Interocular Results
- It's a good thing we don't get all the government we pay for
- Knowledge Trading
- Laboratory vs. Field Studies
- Legalism (LEG)
- Let 'em Fail!
- Locke's Madman
- Man in the Gray Flannel Suit
- Management Competencies
- Measuring Interim Progress in R&D
- Men, Machines and Modern Times - Elting Elmore Morison
- Milestones
- Mother Nature Left the Building
- Mysteries and R&D
- New Men
- New Money
- New Organizational Forms
- Occaam's Razor, Cheap Heuristic
- One Person, One Vote, No Proxies
- Opening Session Remarks, DIA 2010
- Ouch!
- Pattern Recognition
- Pay-for-Performance
- Penicillin Breakthrough in the Production Facility
- Perfect Storms
- Personalized Animal Studies
- Phases of Industrial Growth and Decline
- Pig Farmers, Prostitutes and Leverage
- Predictable Funding for Unpredictable R&D
- Product Valuation, Commercial Equation
- Productivity Not Profits
- Punishers, Dissenters and Brainiacs
- Quality and Effectiveness
- Quants Inadmissible
- R&D as a Trusted Partner
- R&D Finance 101
- R&D Productivity: A Dialog
- R&D Strategy
- Ratcheting Royalties
- Reflection-in-Action
- Results That Stand the Test of Time
- Retail Investors As Predictable Funding
- Retrospective Distortion
- Scientific Competitive Edge
- Separation of Voting Rights from Cash Flow
- Shots on Goal
- Signals in R&D
- Skunkworks
- Special Interest Groups
- Statistics and A>B
- Sustainability of Management Tools
- Systemic Risks
- Tailspin - An Editorial
- The 30-70 Rule
- The Challenge of Brash Citizens
- The Devil Incarnate
- The Mystery of Patient Compliance Levels
- The POW Priest
- The Power of Ownership
- The R&D Narrative
- The Sandbox Challenge
- Theory vs. Empirical Results
- There is No Metric for Creativity
- Three Body Problem
- Tiers of Evidence
- Ties That Bind
- Today's Pharmaceutical Industry Going Forward
- Tolerance for Ambiguity
- Trust and Redemption
- Tyranny of Efficiency
- Tyranny of Models
- Undermine Prevailing Orthodoxies
- Valuation Change Request
- Voting Constructs
- Watchdog
- We Do Not Commit Investors for the Duration
- We Use Comparison Studies to Fool Others...
- What do I get for all my effort in World Class R&D?
- What is this World Class R&D in a nutshell?
- What to Look for in Tools II
- What We Learn from McD
- Why Blockbusters?
- Why Push As Far As Commercialization?
- Why the World Class R&D Institute...
- Windfalls Can Be a Curse...
- World Class R&D Alternate to Pharma in Decline
- World Class R&D and Early Biotech
- World Class R&D Budgeting
- World Class R&D Defined
- World Class R&D Going Forward
- World Class R&D, Take II
- World Class R&D, Take III
- You Get the Answer You Want
- You Have to See It to Believe It
- Frequently Asked Questions
- Are these quotations for real?
- Explain Franchise Capital Management in a Nutshell
- Has anyone done this?
- How am I protected against Spam?
- How do I do RSS with this website?
- I can't seem to wrap my mind around this World Class R&D. Help me.
- I have a great discussion to contribute, but don't know where to place it? Forum, User News, etc.
- If I learn all the material on this site will I become a World Class manager?
- Two disciplines are noticibly absent in World Class R&D: Project Management and Information Technology
- What are the academic underpinnings of World Class R&D?
- What are you looking for in your Board Members?
- What is this World Class R&D in a nutshell?
- What's the story behind the technology used for the website -- Drupal?
- When I submit materials why can't I get formatting like I'm used to in my word processor?
- Where's the really good stuff?
- Which feeds are syndicated on this website?
- Front Page
- Boot Camp
- Breathing Life into Intellectual Capital
- Bringing It All Together - Franchise Capital Management
- Buffeting Winds - Examples of Protections
- Buffeting Winds of the Corporation - Introduction
- C-level Behaviors
- Case Study - Trial by Jury
- Case Study – #006 R&D Acquisitions
- Cautions
- Citizens
- Commentary on End-Game
- Commercial Management and Investible Units
- Commercialization Overview
- Commercialization Strategy
- Community
- Create a Scientific Competitive Advantage
- Employees in End-Game
- Franchise Management and Investible Units
- From Unpredictable R&D to Predictable Investor Returns
- Get Everybody on the Same Page
- How to End
- How to Implement Management Tools
- How to Use Tools
- Implementation
- Intellectual Property in End-Game
- Introduction to Franchise Capital Management
- Introduction to Management Tools & Techniques
- Investible Units
- It's a Package Deal
- It's a Vast Untapped Market
- It’s All About Personal Success
- Leaky Pipes
- Locke's Madman
- Making Good Leaders Great
- Many Routes to Success, Few to Failure
- Mid-Game Overview
- Mutually Assured Destruction - The Nuclear Option
- No Blowin' Smoke
- No Excuses
- No Mechanics Allowed...
- Not a Numbers Game
- Operating Models Overview
- Portfolio Management and Investible Units
- Pre-game Sets the Stage for Success
- R&D as a Trusted Partner
- R&D Protection Mechanisms
- Real Progress
- Rights of First Refusal
- Rules
- Signals in R&D
- Smaller is Better? No, Start-Ups are Small.
- Supply of high caliber investments
- Team Passions and Motivations
- The Cooperative Solution
- The Island Nation of R&D Inc.
- There is No Metric for Creativity
- Timely Halt to Untenable Pursuits
- Use of Allies in R&D Protection
- Valuation of Intellectual Capital
- Venture Management and Investible Units
- We Let Partners Get Under Our Skin
- We Love Investor Exits
- What About Success?
- What Can Possibly Go Right?
- What to Look for in Tools
- Where to Look for New Tools
- Why End?
- Why It Pays to End Well
- World Class R&D Budgeting
- You Know You've Arrived When...
- Images
- 30-70 Rule
- A>B in Comparator Trials
- About Us
- Accelerating Growth Rate
- ACH & Behavior Fundamentals
- ACH and A'C'
- Achieving Management Competencies
- Ad Hoc Hypothesis Generation
- Alternate Views of R&D
- Amoebas and Scope
- Analemma
- Antibiotic Zinc Warning
- Anticipating, Preventing, Reacting
- Archimedes Lever
- Arms-Length Transactions
- Asset Appraisal
- Asset Appraisal
- Assuaging Investor Fears
- At Each Other's Throats
- Autonomous Protection Mechanisms
- Avenues to Build Investor Retention
- Behavior Fundamentals
- Behavior Fundamentals Listing
- Behavior Types
- Behavioral Design Approach
- Behavioral Mechanism Matrix
- Behaviors and Trust
- Behaviors from 2006 Survey
- Behaviors in Evidence Gathering
- Big Steel
- Bill of Rights
- Billion Dollar Bill
- Black Swan
- Black-Eyed Galaxy
- Blinded Compliance Measurement Container (DoseCue)
- Body of Evidence
- Bonuses and Productivity
- Boot Camp
- Brainiacs
- Brash Citizens
- Breakthroughs
- Bringing the Future Forward
- Buddy N.
- Buffeting Winds of the Corporation
- Building Blocks
- Burying of Talents
- C-level Behaviors
- Career Passion in R&D
- Carrot and Stick
- Caution
- Chance, Nécessité, et Naïveté
- Checklists and Criteria
- Chinese Crested Hairless Dog
- Circular Flow
- Citizen Participation
- Commentary on End-Game
- Commercial Dimensions
- Commercialization Milestones
- Commercialization Overview
- Commercialization Team Members
- Commercialization Tools & Techniques
- Common Gaps in R&D Business Sense
- Competition
- Complexity
- Components of Evidence Gathering
- Compulsories in Evidence Gathering
- Compulsories, Risk & Uncertainty
- Consequences
- Context in Clinical Trials
- Copper Interconnects
- Creativity Cannot Be Measured
- Creativity in Commercialization
- Cubbyholes
- Curse of Windfalls
- Deadline Bias
- Decision Authority
- Decision Making Biases
- Decision Structures, Risk & Uncertainty
- Decline of the Pharmaceutical Industry
- Design Criteria for R&D
- Design of Work Practices
- Desired Paths
- Diagnostic Tools
- Diamond in the Rough
- Diminishing Return on Diversification
- Disconfirming Evidence
- Discussion Arena - Clarity
- Disturbing Thought
- Do as I Do
- Domino Causality
- Don't Tread on Me
- Don't Waste a Crisis
- Dose Response Curve
- Drug Motifs, 20th Century
- Dual Class Capitalization
- Dumb Money
- Edmund Rack
- Efficiency vs. Effectiveness
- Eggs in One Basket
- Employee Stock Option Plans (ESOP)
- Employees in an End-Game
- Encino Motel
- End-Game Decision Diagram
- Entry Bar Set High
- Escalation
- Ethical Research
- Excitement vs. Operating Funds
- Exclusive Membership
- Expect the Unexpected
- Faith What's to Come
- Fall of Factory R&D
- Finance 101
- Flexibility of Pursuit in R&D
- Focus Areas vs. Governance Structure
- Force Field Analysis
- Forced-Fit Budgeting
- Frames of Reference
- Franchise Benefits
- Franchise Capital Mgmt. Roles
- Franchise Structure
- Franchisee Ownership Restoration
- Franchisee-In-Charge
- Free-Format Proposal
- Freedom & Responsibility
- Freedom and Dissention
- Funding Innovative R&D
- Future Only Dimly Seen
- Generalization
- Gestalt
- Getting There
- Governance Components
- Governance Infrastructure
- Governance of Risk & Uncertainty
- Governance Principles
- Governance Structure
- Government Response
- Graduation
- Grant of Decision Authority
- Here
- How Research Gets Done
- How to End Well
- How to Implement New Tools
- How to Use Mgt. Tools
- Human Condition
- Hypnotic Effects of Empirical Evidence
- Illogical R&D
- Illustrative Developmental Challenges
- Implementation
- Implementation Variables
- Inductive Probabilistic Reasoning (IPR)
- Inference then Observation
- Inflection Point
- Insecurities of the Highly Educated
- Insourcing vs. Outsourcing
- Insult Versus Response
- Intellectual Capital Wealth Flows
- Intellectual Property in End-Game
- Intellectual Property Repository
- Interest Groups of R&D
- Interocular Results
- Introduction - Mgmt. Tools
- Investible Unit
- Investible Unit Announcement
- Investible Unit Front Page Image
- Investment Behaviors
- Investment Categories
- Investments for Effectiveness
- Investors Exit at Will
- Investors Vote with their Feet
- It's Who We Are
- It’s All About Personal Success
- Join or Die
- Kanzius
- Key Areas of Focus - Manufacturing
- Key Areas of Focus - R&D
- Key Behavioral Moments
- Knowledge is Power
- Knowledge Management Layers
- Layering of Budget Protection
- Leaky Pipeline
- Let 'em Fail
- LiveScribe Wireless Pen
- Locke's Madman
- Locke's Madman 2
- Locke's Madman III
- Look Forward, Look Backward
- Making Good Leaders Great
- Many Routes to Success
- Maturity Matrix
- Maturity Matrix Focus & Users
- McD Field Studies
- McDonalds
- Means Toward Effectiveness
- Mental Models
- Mid-Game Overview
- Milestones
- Mini-Clini's
- Mirror Imaging
- Modern Times (C. Chaplin)
- Monte Carlo Simulation
- Montréal-Mirabel International Airport
- Moses and the Decalogue
- Mutually Assured Destruction
- Mysteries and R&D
- New Men
- New Money
- No Blowin’ Smoke
- No Counting Allowed
- No Excuses
- No Mechanics Allowed...
- No Room at the Inn
- No Rules
- Not a Numbers Game
- Nuggets
- Offshore Banking
- On the Same Page
- One Person, One Vote
- Operating Model
- Operating Model Top Level
- Organizational Form and Behaviors
- Other People's Money
- Our Tree-lined Community
- Outsource the FDA
- Overcoming All Obstacles
- Overlap Funding-Effectiveness
- Oversight balances behaviors
- Patient Compliance Container
- Pattern Recognition
- Pay for Performance Support Structure
- Pay-for-Performance
- Perfect Storms
- Perpetual Fund - Profile View
- Perpetual Fund - Top View
- Perpetual Fund Valuation Exercise
- Personalized Animal Studies
- Phoenix Rising
- Pie Tin Reflector
- Pile of Stuff
- Placebo Effect
- POW Priest
- Power of Ownership
- Product Valuation
- Production Vat
- Productivity Not Profits
- Proxy Measurement Graphs
- Proxy Measurement Locations
- Quality and Effectiveness
- Quantitative Analysis Sweet Spot
- Quantitative Man
- R&D Bill of Rights and Obligations
- R&D Narrative
- R&D Strategy
- R&D vs. Mfctg.
- Ratchet Mechanism
- Real Progress
- Redemption
- Regrets
- Regrets
- Religious Outsiders
- Research Contract
- Research Procedures nACHr
- Researchers Don't Trust...
- Retrospective Distortion
- Revelation
- Rights of First Refusal
- Risk & Uncertainty Components
- Risk Mgt. Framework
- Role of Governance in Evidence
- Rotoscoping
- Safe Conduct Pass
- Sandbox Challenge
- Satisfaction
- Scorecard
- Sense of Ownership
- Shared Space
- Shifting Goalposts
- Signals
- Signals and R&D
- Simpson's Paradox
- Skunkworks
- Slippery Science
- Smaller is Better
- Smokers Sleep Less Soundly
- Socratic Dialog
- Special Interest Groups
- Stage Set for Success
- Stages of Industrial Growth
- Stand the Test of Time
- Storm Clouds at the FDA
- Strategic Goals of R&D
- Success Rates and Diversification
- Survey Behaviors - Bias
- Survey Behaviors - Insecurities
- Survey Behaviors - Risk
- Surveys Humor
- Systemic Risks
- Tag Cloud of World Class R&D Terminology
- Tailspin
- Team Meshing
- Term Sheets
- The Commercial Equation
- The path towards mini-clini’s
- There
- Thing, G.K. Chesterton
- Three Body Challenge
- Three Pillars of Funding Success
- Tiers of Evidence
- Ties That Bind
- Today's Pharma Going Forward
- Tolerance for Ambiguity
- Tom Cruise
- Ton of Freight
- Tonic Music Club
- Trial & Error
- Trial by Jury
- Trial by Jury II
- Trusted Partner
- Turmoil
- Two-Way Franchise Fees
- Tyranny of Efficiency
- Tyranny of Models
- U.S. Venture Capital Statistics
- Undermine Prevailing Orthodoxies
- Unexpected Findings
- Unexpected Findings 2
- Unpredictable If, When and Where
- Unproductive Behaviors
- Valuation Change Request
- Watchdog
- WCRD Scope
- We Bring Dead Assets Alive
- Wealth Created in the Mind
- Web of Financial Relationships
- Whac-a-Mole and Behaviors
- What About Success?
- What If Scenarios
- What to Look For
- What to Look for in Tools II
- Where to Look for New Tools
- Who's the Customer?
- Why Do We End?
- Why It Pays to End Well
- Why the Institute?
- Windfalls to Predictability
- Windfalls to Predictability Image
- Windfalls, Share Price and Risk
- WIP Counting
- Work Practices for Mgt. of Risk & Uncertainty
- World Class R&D and Early Biotech
- World Class R&D Going Forward
- World Class R&D in Pharma
- World Class R&D, Take III
- Worm Filled Apple
- Worst Practices
- Newsletter
- Newsletter – Buffeting Winds (Vol. 1, No. 5)
- Newsletter – Commercialization Investment Category (Vol. 1, No. 6)
- Newsletter – End-Game Investment Category (Vol. 1, No. 7)
- Newsletter – Franchise Capital Management (Vol. 2, No. 2)
- Newsletter – Introduction to the Investible Unit (Vol. 1, No. 1)
- Newsletter – Mgmt. Tools & Techniques (Vol. 2, No. 1)
- Newsletter – Mid-Game Investment Category (Vol. 1, No. 4)
- Newsletter – One Person, One Vote (Vol. 2, No. 3)
- Newsletter – Pre-Game Investment Category (Vol. 1, No. 3)
- Newsletter – R&D Operating Models (Vol. 1, No. 2)
- Quotations
- A convention manager shows up in Moscow to finalize hotel accommodations…
- A legitimate hallmark is unexpected behavior that leads to deeper understanding…
- A political entrepreneur refers to a political player who seeks to gain...
- A … vision of [an] underlying unity illuminating nature and humankind is…
- All scientific work is incomplete – whether it be observational or experimental.
- As a man's income increases, so the sacrifice of risk-taking becomes less ...
- Ask any magician ... and they will tell you that there is no better audience…
- Be thankful we’re not getting all the government we’re paying for.
- Before, I knew everyone by name. We were a close-knit team...
- But these small research firms specialize in the development of prototypes!
- Can you imagine. We did this for free, as our hobby...
- Civilization advances by extending the number of important operations…
- Consider the story about the ignorant businessman, the intelligent businessman and the wise
- Controlled variation is the foundation of empirical scientific knowledge
- Don't talk to me about aesthetics or tradition. Talk to me about what sells…
- Don’t trust the Federal Reserve? Then consider mobile money.
- Dr. Moriarity, a metaphysician, sets up fifty numbered dominoes...
- Exploratory Data Analysis lets the data speak to you without the interference of models.
- Faith is the realization of what is hoped for and evidence of things not seen
- Faith, if it is ever right about anything, is right by accident.
- Get me FDA approval on concrete in a capsule and I can sell it!
- Gilbert’s lab … the tone of the place was casual, almost fiercely informal
- Head of R&D to CEO: You are not qualified to understand the science behind this research proposal.
- Here are my annual goals. This book lists all the projects we're working on in R&D.
- How much will it cost to move Mount Fuji 100 miles to the north?
- I can’t just include the quantitative results from my experiments in the shared database.
- I do the very best I know how, the very best I can, and I mean to keep doing so…
- I don’t know how we’re going to be able to do this without you.
- I had never felt such an intense experience in my life...
- I have no need for World Class R&D. I discovered the Acme blockbuster product.
- I just contribute a small portion to the overall success of commercialization.
- I know the obvious winners and losers...
- I know what being effective means when we talk about the claims process…
- I started off as an accountant, but my bosses quickly realized…
- I take from the rich and give to the middle class. Well, the upper middle class.
- I very much believe in the Lipinski Rule of Five...
- I wasn't totally unaware of the number of people who had failed...
- I worked at a start-up. It was fun.
- I would go into these meetings with 6-10 individuals from research...
- I would go to these cocktail parties held by the CEO. All the top brass would be there...
- I would go to these meetings where the CEO would expound...
- I'm not talking about publicity, Bob.
- If a human intelligence tried to examine and judge all the particular cases …
- If I only have one or two investments the researchers can blow smoke in my eyes.
- If we can agree the problem is mainly one of rapid adoption to changes…
- If you keep sending me losers, there’s only so much I can do to stem the bleeding…
- If you're faced with a traffic signal, you don't have to think anymore...
- In 1995 a comprehensive review of [fingerprint] examiner proficiency was performed...
- In a meeting to trade research insights...
- In the dictator game, the sociologist/economist places $100 on a table...
- In their 1985 quest to attract funding for new biotech research ...
- Innovation must be financed by turning to ...credit above and beyond the circular flow
- Inside Gilbert’s lab, the paramount concerns were novel information and speed
- It is incumbent on us all to work toward understanding ‘big picture' issues…
- it occurred to me that for something of this importance, that there was enough money
- It seems to me that anything that can be taught is relatively inconsequential...
- It takes a special kind of person to overcome these difficulties.
- It's hard to do good science when you're always looking over your shoulder.
- It’s amazing. We forecast a full 18 months in advance...
- I’m so p’d off. I just received a poor performance review. I’m quitting.
- I’ve had plenty of days when all my trades worked, quickly taking me over my profit expectations
- Just build this database! I’m certain it will give untold benefits to millions...
- Layers of depth or specialization can be pursued…
- Liberty means responsibility. That is why most men dread it.
- Makes a businessperson a little twitchy.
- Man simply overreaches himself...
- Man with no Medical Training Cures Cancer in His Basement
- My first reaction to that is: Are you kidding me? Do you really think you've been able...
- Myth: The facts will set us free. Reality: Narratives, not facts, guide our thinking.
- Never let a serious crisis go to waste...
- Over long periods of time, small differences in rates of productivity...
- Perhaps the fact that we have seen millions voting themselves into...
- Politics is the art of looking for trouble, finding it everywhere...
- Probably the most important thing is doing this in the right places...
- Public management is not an arena in which to find Big Answers
- Pull together an analysis that shows why this project should take place in Ensenada.
- Pull together an industry survey that will show how our firm is at the bottom…
- Put all your eggs in one basket and watch that basket.
- Reports that say that something hasn't happened are always interesting to me…
- Scientific research ... evolves over time through generally incremental changes…
- Since there have been literally thousands of utopian, cooperative ...
- Situs inversus, the left-to-right transposition of all internal organs...
- Some would-be advisor puts a logo on some fancy stationery...
- Strategy is the expression of intent used to direct all actions…
- The directors of such companies, however, being the managers of other people's money...
- The executive exists to make sensible exceptions to general rules.
- The general atmosphere... these people moved always in a field of resistance
- the innovators, the men without heavy commitments to the system
- The marketing department estimated first year sales of Lipitor™ at 200-300 million U.S. dollars.
- The mechanism of action of Methotrexate in Rheumatoid Arthritis is currently unknown.
- the medium gave them the opportunity to express themselves in new ways
- The past century has been the one and only century...
- The path from laboratory breakthrough to commercial production remains tortuous…
- The reason a compound is placed in the compound library is because it's already dead.
- The reason that God was able to create the world in seven days...
- The system of peer review is biased, unjust, unaccountable, incomplete…
- The U.S. market will not embrace your ideas. Head to Asia...
- The upcoming conference on the growing threat from the Antarctica ozone hole…
- The value of fiat money and its acceptance in transactions emerge as properties
- The way I really taught myself to become a day trader…
- There are just too many moving parts that have to be synchronized…
- There exists in such a case a certain institution or law...
- There is one question to answer in the decision-making process.
- There once was a man name of Gödel. Whose work gave logicians a hurdle.
- These people honor me with their lips, but their hearts are far from me.
- These worked very well, until some years later the SEC decided...
- Today’s crop of senior latent fingerprint examiners rose through the ranks…
- Two peer review panels were both given the same papers to adjudicate…
- We can’t do any of the changes you recommend
- We don’t want our researchers distracted with commercial concerns.
- We had six researchers we really wanted to keep...
- We had to place many hundreds of millions of dollars of pension money...
- We have met the enemy and he is us.
- We have one of the best electronic patient record systems of any major hospital group...
- We know the weaknesses of using portfolio analysis to make our investment decisions…
- We set up an outsourcing mechanism...
- We suffer from a confusion of ideas about what people need to know ...
- We tried counting work-in-process
- We were brought in to automate a very tedious operation in research.
- We worked with one of the top management-consulting firms…
- We would go to these CEO conferences...
- We would hold wakes at the death of a project...
- Well, I don't know as I want a lawyer to tell me what I cannot do...
- We’ve tried that and it doesn’t work.
- What are you going to tell me that every other consultant hasn't already said?
- Why have any employees at all? Why have a building? Why not just sit [at] home...
- With Lipitor™ we could have lowered the dosage to be much safer...
- Without firm fixed goals folks declare victory regardless of the outcome...
- Without some dissimulation no business can be carried on at all.
- You can’t fix stupid
- You have to know the rules in order to be able to break them.
- You must build a methodology for deciding go / no-go at each stage...
- You'll be able … to drop the old ways of people management...
- Book Reviews
- Accountability: Freedom and Responsibility without Control
- Against Method
- Analyzing Intelligence
- Black Swan, The
- Bureaucracy
- Concepts and Categories
- Corporate Creativity
- Curing Analytic Pathologies
- Damned Lies and Statistics
- Democracy In America
- Dip, The
- Drug Discovery
- Economic Theory of Risk and Insurance
- Economist’s View Of The World
- Educating the Reflective Practitioner
- Enlightenment in America, The
- Evidence
- Evidence, Proof, and Facts: A Book of Sources
- Evolution of Cooperation
- Expert Judgment: How Good Is It?
- Exploratory Data Analysis
- Fifth Discipline
- Fine Art of Propaganda, The
- Getting to Yes
- Goal, The
- Heuristics And Biases
- Honest Broker, The
- How Doctors Think
- How to Read a Paper
- ImmunoBiology
- Integration of Pharmaceutical Discovery and Development
- Intelligence
- Judgment In Managerial Decision Making
- Judgment under Uncertainty: Heuristics and Biases
- Managing The Unexpected
- Mathematics and the Unexpected
- Men, Machines and Modern Times
- On War
- Origins of Totalitarianism
- Peloponnesian War, The
- Philosophy Of Mathematics
- Physical Universe
- Pioneer Preacher, The
- Politics Among Nations
- Prince, The
- Psychology of Intelligence Analysis
- Religious Outsiders And The Making Of Americans
- Responsible Self, The
- SAGE Handbook of Evaluation, The
- Scientific Method In Practice
- Semisovereign People, The
- Suspect Identities
- The Mystery of Capital
- Thing, The
- Weird Ideas That Work
- User News
- Behaviors Couldn't Get Any Worse
- Black Swan
- Build It and They'll Come
- Decline of the Pharmaceutical Industry
- Efficiency vs. Effectiveness
- Freedom and Dissention
- Generalization
- Gestalt
- Government Response to Pharma in Decline - Editorial
- Heterogeneity of the Placebo Effect
- How much does it cost for that train to move a ton of freight?
- Locke's Madman
- Measuring Interim Progress in R&D
- Mysteries and R&D
- Opening Session Remarks, DIA 2010
- Personalized Animal Studies
- Punishers, Dissenters and Brainiacs
- Signals in R&D
- Smaller is Better? No, Start-Ups are Small.
- The 30-70 Rule
- The Devil Incarnate
- The Mystery of Patient Compliance Levels
- Tyranny of Efficiency
- We Use Comparison Studies to Fool Others...
- What do I get for all my effort in World Class R&D?
- What We Learn from McD
- World Class R&D Budgeting
- World Class R&D Going Forward
- World Class R&D, Take II
- World Class R&D, Take III
- You Have to See It to Believe It
- Websites
- 2003 Foot-In-Mouth winner of the Plain English Campaign
- A Game of Cat and Mouse (Subscription Required for Full Access)
- A GUIDE TO RESOURCES ABOUT THE HISTORY OF DRUGS AND MEDICINES
- A Measure for Crackpots
- A Narrow Road to Cooperation (Subscription Required for Full Access)
- A Stock-Market Scam
- A WEIRD View of Human Nature Skews Psychologists' Studies (Subscription Required for Full Access)
- Applying Military Theory to Bankruptcy Battlegrounds
- Basic Research, Applied Research, and Innovation in the Semiconductor and Pharmaceutical Industries
- Biographies of the Discoverers of Medicines
- Bosses Don't Wear Bunny Slippers: If Markets Are So Great, Why Are There Firms?
- Business process reengineering - Wikipedia
- Calming Traffic by Losing the Signs
- Causal Inference (Chapter 9 of Understanding the fundamentals of epidemiology: an evolving text)
- Chance, Nécessité, et Naïveté: Ingredients to create a new organizational form
- Clinical attrition due to biased preclinical assessments of potential efficacy (Subscription Required for Full Access)
- Common Law -- Historical Roots., Relation to Civil Law ...
- Concept and Measurement of Productivity
- Conscious Competence Learning Model
- Consumer Behaviors
- CREATIVE HYPOTHESIS GENERATING IN PSYCHOLOGY: Some Useful Heuristics
- Credit default swaps - Deutsche Bank Research
- Curing Analytic Pathologies
- Democracy in America (Volume 2, Part 1, Chapter 3)
- Discontinuous Innovation and the Growth Paradox
- Drug discovery in jeopardy
- Econtalk: Daniel Pink on Drive, Motivation, and Incentives
- Erosion of R&D's Value
- Establishing portfolio management governance: Key components
- Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease (Subscription Required for Full Access)
- Falsifiability
- Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations (Subscription Required for Full Access)
- Freakonomics - Day-Care Center Anectdote
- From Complexity to Perplexity
- Galenic Medicine
- Geometry is All - Economist
- German Town's Traffic Plan: Remove Signs, Curbs
- Half Cost Products
- Hawthorne effect - Wikipedia
- Highly Variable Spread Rates in Replicated Biological Invasions: Fundamental Limits to Predictability (Subscription Required)
- How to set up a 'backburner' to capture and review your ideas
- Ill-defined Property Rights in Collective Action - The Case of U.S. Agricultural Cooperatives
- Images of Organisation and Development of Information Society: Going into Metaphors
- Information asymmetry - Wikipedia
- Integrating Heterogeneous Pieces of Evidence in Systematic Reviews
- John Horton Conway's The Game of Life
- John Tukey (1915-2000): Deconstructing Statistics
- Kanzius Cancer Research Foundation
- Lab Experiments Are a Major Source of Knowledge in the Social Sciences (Subscription Required for Full Access)
- Lagrangian Points - Wikipedia
- Learning More about the 16 MBTI® Personality Types - Dominant Extraverted Intuition
- Lipinski's Rule of Five
- Management Teams – Why They Succeed or Fail
- Marketing and Discontinuous Innovation
- Mathematics and Complex Systems (Subscription Required for Full Access)
- Mirror-Image Humans Walk Among Us With No Warning
- Munger on Many Things - EconTalk
- Munger on the Nature of the Firm
- Obama Weighs Quick Undoing of Bush Policy
- On War, Book 6 (Defense), Chapter 1
- One Share, One Vote: The Empirical Evidence
- Open Secrets: Enron, intelligence, and the perils of too much information
- Opposition Research (Wikipedia)
- Optimally Interacting Minds (Subscription Required for Full Access)
- Pharmaceutical Industry Readiness for a Phaseless Approach to R&D
- Process Tracing in Case Study Research
- Proteins that Promote Long Live (Subscription Required for Full Access)
- Psychology of Intelligence Analysis
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virus (Subscription Required for Full Access)
- Recent Warming Reverses Long-Term Arctic Cooling (Subscription Required for Full Access)
- Receptor concept: pharmacology's big idea
- Resolving Scientific Dispute by the Joint Design of Crucial Experiments by the Antagonists
- Roberts (and Hanson) on Truth and Economics
- SAP R&D Management Modules
- Secret World of Mike Milken
- Sex, Lies and Videotape . . . and Murder
- Shared space
- Simpson's Paradox, Wikipedia
- Smith, Adam (1776). An Inquiry into the Nature and Causes of the Wealth of Nations
- Sokal Affair
- Solving the Puzzle of Human Cooperation
- Something Out of Nothing - The Placebo Effect
- Spiritual Exercises of Ignatius of Loyola - Wikipedia
- Stalking Cholesterol - Feat of Japan's Dr. Endo
- Superconductivity's Smorgasbord of Insights: A movable Feast (Subscription Required for Full Access)
- Suslick's Laws of the Universe
- The Biofuels Landscape Through the Lens of Industrial Chemistry (Subscription Required for Full Access)
- The Brains Behind Blockbusters (Subscription Required for Full Access)
- The Competitive Advantage of Sanctioning Institutions (Subscription Required for Full Access)
- The Conference Board
- The Environment and Disease: Association or Causation?
- The great Satans of Chinese history, the group of philosophers and administrators known as the Legalists
- The One Share - One Vote Debate: A Theoretical Perspective
- The Peloponnesian War
- The R&D strategy/strategic process
- The Theory of Money
- The Truth Wears Off
- The Ultimate Decision Making Process
- The Use of Knowledge in Society, Hayek, Friedrich A.
- Thinking Out of the Style Box
- Three Body Problem - Wikipedia
- Tolerating the Uncertainty Principle
- Toward an AIDS Vaccine (Subscription Required for Full Access)
- Towards a Risk Maturity Model
- Twilight for the Enlightenment?
- Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial
- Venture Capital, Double-Sided Adverse Selection, and Double-Sided Moral Hazard
- Via Freedom to Coercion: The Emergence of Costly Punishment (Subscription Required for Full Access)
- Water Freezes Differently on Positively and Negatively Charged Surfaces of Pyroelectric (Subscription Required for Full Access)
- What Do Firms Do With Cash Windfalls?
- What Would Machiavelli Do?
- When the Underwriter is the Market Maker
- Why New Management Model?
- Why Smart People Believe Weird Things: Excerpt
- Zinc Content of Intravenous Bags
- What If
- Core Arguments
- Applicability of the Prescriptions, Key Areas of Focus
- Background & Understanding, Mgt. of Risk & Uncertainty
- Behavior Fundamentals, Organizational Behaviors
- Behaviors, Evidence Gathering
- Behaviors, Key Areas of Focus
- Caution, Organizational Behaviors
- Challenges, Evidence Gathering
- Commentary, Governance
- Commentary, Maturity Matrix
- Compared to Manufacturing 1(2), Key Areas of Focus
- Compared to Manufacturing 2(2), Key Areas of Focus
- Components, Governance
- Compulsories, Evidence Gathering
- Compulsories, Mgt. of Risk & Uncertainty
- Decision Authority, Governance
- Decision Structures, Mgt. of Risk & Uncertainty
- Evidence Gathering, Maturity Matrix
- Evidence-Based Management, Organizational Behaviors
- Governance, Maturity Matrix
- Introduction, Evidence Gathering
- Introduction, Governance
- Introduction, Key Areas of Focus
- Introduction, Maturity Matrix
- Introduction, Mgt. of Risk & Uncertainty
- Introduction, Organizational Behaviors
- Mgt. of Risk & Uncertainty, Maturity Matrix
- Organizational Behaviors, Maturity Matrix
- Oversight, Governance
- Principles, Governance
- Product Safety, Evidence Gathering
- Role of Governance, Evidence Gathering
- Role of Governance, Mgt. of Risk & Uncertainty
- Scope, Evidence Gathering
- Signals, Organizational Behaviors
- Structure, Governance
- Sustainability, Governance
- Work Practices, Evidence Gathering
- Work Practices, Mgt. of Risk & Uncertainty
- Work Practices, Organizational Behaviors
- New Items
- Roadmap
